| Andrew R Hetland, MD | |
|
2331 Tyler Pkwy Ste 6, Bismarck, ND 58503-0871 | |
| (701) 258-6851 | |
| Not Available |
| Full Name | Andrew R Hetland |
|---|---|
| Gender | Male |
| Speciality | Otolaryngology |
| Experience | 20 Years |
| Location | 2331 Tyler Pkwy Ste 6, Bismarck, North Dakota |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1457302622 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Y00000X | Otolaryngology | 1696 (Wisconsin) | Secondary |
| 207Y00000X | Otolaryngology | 11581 (North Dakota) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Chi St Alexius Health | Bismarck, ND | Hospital |
| Sanford Medical Center Bismarck | Bismarck, ND | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Hetland Ear Nose Throat Pc | 5496037038 | 4 |
News Archive
Boehringer Ingelheim, one of the world's leading pharmaceutical companies, announced recently the launch of the 'In Reach Africa' program, an initiative aimed at facilitating quality and innovative human and animal healthcare access across the African continent.
Apricus Biosciences, backed by a revenue generating CRO business and seeking to leverage its multi-route NexACT® drug delivery technology and internal pipeline through out-licensing partnerships, today announced that it has entered into agreements with selected investors to sell up to 1,728,882 Units at a price per Unit of $5.40, for aggregate gross proceeds of approximately $9.3 million.
Can you ditch the strips and dump the dentist for whiter teeth? From "The Dr. Oz Show" to YouTube videos, experts say you can reclaim those pearly whites simply by mixing fruit, such as strawberries, with some baking soda, and applying the all-natural concoction to your teeth.
Research from the Regenstrief Institute and the Indiana University Center for Aging Research has found that many family caregivers of older adults with dementia are willing to consider stopping cancer screening of the elderly individual; they are also relieved when the older adult's physician brings it up.
Incyte Corporation today announced that its strategic collaborator, Novartis, received approval from the European Commission for Jakavi (INC424, ruxolitinib), an oral JAK 1 and JAK 2 inhibitor discovered by Incyte, for the treatment of disease-related splenomegaly or symptoms in adult patients with primary myelofibrosis (also known as chronic idiopathic myelofibrosis), post-polycythemia vera myelofibrosis or post-essential thrombocythemia myelofibrosis.
› Verified 7 days ago
| Entity Name | Hetland Ear Nose Throat Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1932642790 PECOS PAC ID: 5496037038 Enrollment ID: O20170117000360 |
News Archive
Boehringer Ingelheim, one of the world's leading pharmaceutical companies, announced recently the launch of the 'In Reach Africa' program, an initiative aimed at facilitating quality and innovative human and animal healthcare access across the African continent.
Apricus Biosciences, backed by a revenue generating CRO business and seeking to leverage its multi-route NexACT® drug delivery technology and internal pipeline through out-licensing partnerships, today announced that it has entered into agreements with selected investors to sell up to 1,728,882 Units at a price per Unit of $5.40, for aggregate gross proceeds of approximately $9.3 million.
Can you ditch the strips and dump the dentist for whiter teeth? From "The Dr. Oz Show" to YouTube videos, experts say you can reclaim those pearly whites simply by mixing fruit, such as strawberries, with some baking soda, and applying the all-natural concoction to your teeth.
Research from the Regenstrief Institute and the Indiana University Center for Aging Research has found that many family caregivers of older adults with dementia are willing to consider stopping cancer screening of the elderly individual; they are also relieved when the older adult's physician brings it up.
Incyte Corporation today announced that its strategic collaborator, Novartis, received approval from the European Commission for Jakavi (INC424, ruxolitinib), an oral JAK 1 and JAK 2 inhibitor discovered by Incyte, for the treatment of disease-related splenomegaly or symptoms in adult patients with primary myelofibrosis (also known as chronic idiopathic myelofibrosis), post-polycythemia vera myelofibrosis or post-essential thrombocythemia myelofibrosis.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Andrew R Hetland, MD 2331 Tyler Pkwy Ste 6, Bismarck, ND 58503-0871 Ph: (701) 258-6851 | Andrew R Hetland, MD 2331 Tyler Pkwy Ste 6, Bismarck, ND 58503-0871 Ph: (701) 258-6851 |
News Archive
Boehringer Ingelheim, one of the world's leading pharmaceutical companies, announced recently the launch of the 'In Reach Africa' program, an initiative aimed at facilitating quality and innovative human and animal healthcare access across the African continent.
Apricus Biosciences, backed by a revenue generating CRO business and seeking to leverage its multi-route NexACT® drug delivery technology and internal pipeline through out-licensing partnerships, today announced that it has entered into agreements with selected investors to sell up to 1,728,882 Units at a price per Unit of $5.40, for aggregate gross proceeds of approximately $9.3 million.
Can you ditch the strips and dump the dentist for whiter teeth? From "The Dr. Oz Show" to YouTube videos, experts say you can reclaim those pearly whites simply by mixing fruit, such as strawberries, with some baking soda, and applying the all-natural concoction to your teeth.
Research from the Regenstrief Institute and the Indiana University Center for Aging Research has found that many family caregivers of older adults with dementia are willing to consider stopping cancer screening of the elderly individual; they are also relieved when the older adult's physician brings it up.
Incyte Corporation today announced that its strategic collaborator, Novartis, received approval from the European Commission for Jakavi (INC424, ruxolitinib), an oral JAK 1 and JAK 2 inhibitor discovered by Incyte, for the treatment of disease-related splenomegaly or symptoms in adult patients with primary myelofibrosis (also known as chronic idiopathic myelofibrosis), post-polycythemia vera myelofibrosis or post-essential thrombocythemia myelofibrosis.
› Verified 7 days ago
Marcus M Fiechtner, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 715 E Broadway Ave Ste 110, Bismarck, ND 58501 Phone: 701-323-6000 Fax: 701-323-6781 | |
Floyd R Barnhill Jr., MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 225 N 7th St, Bismarck, ND 58501 Phone: 701-323-6000 Fax: 701-323-5709 | |
Walter Parker Moore Iii, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 401 N 9th St, Bismarck, ND 58501 Phone: 701-712-4500 | |
Dr. Marie-pierre Charron, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 715 E Broadway Ave, Bismarck, ND 58501 Phone: 701-323-8922 | |
Dr. Jeffrey J Nelson, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 701 E Rosser Ave, Bismarck, ND 58501 Phone: 701-323-8922 Fax: 701-323-8018 | |
Dr. Steven D Spotts, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 401 N 9th St, Bismarck, ND 58501 Phone: 701-530-6000 Fax: 701-530-6430 |